Health Service Focus

28.07.17

A welcome signal on the future of medicines

Source: NHE Jul/Aug 2017

Just before NHE went to press, Jeremy Hunt and Greg Clark issued a letter entitled ‘the UK wants to continue to work with the EU on medicines’. David Stevenson reports on this and recent discussions around Brexit.

An “important and welcome signal”. These are the words of Niall Dickson, CEO of NHS Confederation and co-chair of the Brexit Health Alliance, after the secretaries of health and industry sent a letter to the Financial Times stating that they want to “provide assurance” over the government’s plans for the regulation of medicines as we leave the EU. 

The letter stated that the UK was “fully committed” to continuing to work closely with its European partners in this area: “We have three principles which will help us rise to the challenge of developing a new regulatory system post-Brexit: patients should not be disadvantaged; innovators should be able to get their products into the UK market as quickly and simply as possible; and we continue to play a leading role promoting public health.”

The letter concluded by stating that, whatever the outcomes of the Brexit negotiations, a regulatory system that protects the best interests of patients and supports the UK life science industry to go from strength to strength will be pursued. But it added: “Our door will always be open to a deep and special relationship with the EU which remains the best way to promote improved patient outcomes both in Europe and globally.” 

Responding to the news, Dickson argued that if we get these negotiations wrong, “there is a real danger that patients could be denied access to cutting-edge treatments, and indeed access to a wide range of innovative health technologies”.

The determination of the UK government to continue with a regulatory system that protects and supports the life science sector is very welcome, he added. 

At Confed17, Dickson launched the Brexit Health Alliance, which brings together the NHS, medical research, industry, patients and public health organisations. Its aim is to make sure that issues such as healthcare research, access to technologies and treatment of patients are given the prominence and attention they deserve in the Brexit negotiations. 

“The current EU medicines research, development and regulatory arrangements work well and benefit from the input of UK academics, regulators and industry,” stated Dickson. “For patients in the UK and across Europe we must maintain the highest possible level of collaboration and regulatory alignment.”  

During a recent discussion at Confed17, Sir Hugh Taylor, former permanent secretary at the Department of Health, the current chair of Guy’s and St Thomas’ NHS FT and co-chair of the Brexit Health Alliance, said that the single biggest risk factor for his trust over the next 12 months is workforce issues. On top of this, approximately 15% of the staff at his trust are EU nationals. 

“I think that risk is, in part, a funding issue,” he said. “But also, in part, it is a related set of issues to do with pay, the cost of housing and transport. But the Brexit impact is a compounding factor on workforce issues.

“We have touched on access for UK citizens, and we need to ensure we have reciprocal arrangements in place. Then there is the issue of access to technologies and the supply chain as we are big importers for medicines and tech. 

“There is quite a lot for the NHS and the Department of Health to get their heads around on supply chain issues. It is important that health is supported by a strong research and innovation base.  Universities and medical schools are dependent on international talent. We need to ensure the research and innovation base is improved as a result of EU negotiations. There are lots of areas to explore and lots of conversations to be had.” 

In support of the line from the health and industry secretaries, Professor Alan Boyd, president of the Faculty of Pharmaceutical Medicine, stated that it is essential that the issues of regulation of medicines and devices are properly resolved for the safety and benefit of patients. 

“We would urge the government to closely involve professional bodies representing clinicians and the industry itself as discussions progress, and seek their input and expert advice to enable the best outcome to be achieved for patients and the industry in the UK,” he concluded.

TELL US WHAT YOU THINK

opinion@nationalhealthexecutive.com

Comments

There are no comments. Why not be the first?

Add your comment

 

national health executive tv

more videos >

latest healthcare news

London trust told to improve for third time in three years

17/08/2017London trust told to improve for third time in three years

A major London NHS trust has been told by inspectors that it needs to urgently improve after it received its third ‘Requires Improvement&rs... more >
Third of trainee GPs not planning to work in NHS general practice

17/08/2017Third of trainee GPs not planning to work in NHS general practice

Only two-thirds of trainee GPs are planning to go on to work in general practice in the NHS, a new study has today warned. The research carr... more >
Longest serving NHS chief executive sacked for ‘gross misconduct’

17/08/2017Longest serving NHS chief executive sacked for ‘gross misconduct’

The NHS’s longest serving CEO Sir Leonard Fenwick has been sacked by Newcastle upon Tyne Hospitals NHS FT (NUT) for “gross misconduct... more >

editor's comment

13/06/2017Tackling the major challenges facing the NHS

As you will have gathered from the front cover, a theme that runs throughout this edition of NHE is about empowering and involving the workforce in order to deliver innovative change across the system.  Professor Jane Dacre, president of the Royal College of Physicians, highlights on page 16 the importance of sustainability and trans... read more >

last word

Your personality, your leadership

Your personality, your leadership

Deirdre Wallace, clinical skills manager at UCL Medical School, discusses the importance of learning about leadership and self while at medical school. Approximately five years ago, I was ch... more > more last word articles >
681 149x260 NHE Subscribe button

the scalpel's daily blog

Turbo-boosting STPs? It’s time we got serious about ‘partnership’

27/07/2017Turbo-boosting STPs? It’s time we got serious about ‘partnership’

Merron Simpson, chief executive New NHS Alliance, argues we’re missing the point of what ‘partnership working’ truly means if we refuse to recruit help from those outside the health service. Jeremy Hunt and Simon Steven’s recent announcement to ‘turbo-boost’ sustainability and transformation partnerships (STPs) provides a welcome shot-in-the-arm for those across the system who are ... more >
read more blog posts from 'the scalpel' >

comment

Changing our digital culture and safeguarding patient data

08/08/2017Changing our digital culture and safeguarding patient data

Joanna Smith, chief information officer at Royal Brompton & Harefield NHS FT (RBHT), says that as the NHS becomes more digital it has to get ... more >
A centre for medicines optimisation research and education

04/08/2017A centre for medicines optimisation research and education

Dr Yogini Jani, a consultant pharmacist at University College London Hospitals NHS FT (UCLH), discusses a collaboration with UCL School of Pharma... more >
Unlocking the benefits of age-friendly cities

04/08/2017Unlocking the benefits of age-friendly cities

Stefanie Buckner, Calum Mattocks and Louise Lafortune from the Cambridge Institute of Public Health, alongside Melanie Rimmer from the School of ... more >
A community service

04/08/2017A community service

Louise Watson, NHS England director of the New Care Models programme, discusses the emerging success stories from the vanguard areas across the c... more >
Diabetes Professional Care launches 2017 Conference programme

03/08/2017Diabetes Professional Care launches 2017 Conference programme

An outstanding line-up of practitioners and thought leaders will share their expertise and knowledge with healthcare professionals from across th... more >

interviews

Improving care at the touch of a screen

08/08/2017Improving care at the touch of a screen

When it comes to dementia, having a calm and safe environment can have a substantial impact on a patient’s quality of life. NHE’s Jos... more >
A new approach to talent management

25/07/2017A new approach to talent management

Martin Hancock, national lead for talent management at NHS Leadership Academy, and Gill Rooke, the organisation’s senior operations manager... more >
Enabling greater integration through ACSs

25/07/2017Enabling greater integration through ACSs

At this year’s NHS Confed, Simon Stevens revealed the first wave of accountable care systems (ACSs). NHE speaks to Ian Dodge, the director ... more >
How NHS organisations can protect themselves against cyber crime

25/07/2017How NHS organisations can protect themselves against cyber crime

On 12 May, a global cyber-attack occurred on an unprecedented scale. It affected organisations across the globe and, though it did not specifical... more >
Working collectively to improve cancer outcomes for patients

20/06/2017Working collectively to improve cancer outcomes for patients

Last year, the cancer vanguard established the Pharma Challenge. Rob Duncombe, pharmacy director at the Christie NHS FT, gives NHE an update on t... more >